… These “acute exacerbations” are defined as discrete episodes of acute, clinically significant
respiratory deterioration characterized by evidence of new widespread alveolar abnormality. …

… Our understanding of PH pathogenesis in PF patients primarily relies on data from idiopathic
pulmonary fibrosis (IPF) [5]. In the recent years, new pathophysiological concepts emerged …

… This description of the group in whom SARS-CoV-2 infection is most lethal is also highly
representative of patients suffering with idiopathic pulmonary fibrosis (IPF). IPF characteristically …

… of patients with idiopathic pulmonary fibrosis (IPF), but their clinical relevance remains unclear…
of ANCAs in a North American population with IPF and evaluate their clinical significance. …

… In 2007, thalidomide was used on bleomycin-induced pulmonary fibrosis in mice and in
2015 it was shown to protect against emphysematous changes in mice exposed to cigarette …

… , and in particular fibrotic interstitial lung disease. Pulmonary fibrosis can be idiopathic and
… chronic inflammation may also be involved in the pathogenesis of lung fibrosis. Importantly, …

… to rapidly identify whether the development of pulmonary fibrosis occurs in the survivor
population. By doing this, we can hope to deliver appropriate clinical care and urgently design …

… clinical trial reporting a beneficial effect of antifibrotic medication in interstitial lung diseases
(ILDs) other than IPF that manifest progressive pulmonary fibrosis (… of pulmonary fibrosis and …

… Findings from both CT and PFT are similar to disorders characterized by pulmonary fibrosis,
where thickened alveolar membranes and interstitial remodelling usually affect gas diffusion …

… Objectives: To evaluate the clinical effectiveness of … pulmonary fibrosis. Methods: Using
a large US insurance database, we identified 8,098 patients with idiopathic pulmonary fibrosis …